SMS Pharmaceuticals Ltd — Major Shareholding Notification 2020

Aug 18, 2020

Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Baniara Hills, Hyderabad - 500 034, Telangana, INDIA. Tel: +91-40-2525 9999, Fax: +91 -40-2525 9889 CIN : L24239TG1987PLC008066 Email: info@smspharm a,com, www.smspharma.com

Date: 18th August, 2020

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exch ange Plaza, Plot no, C/ I, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 05 1.

Security Code: 532815

Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Reporting under Regula tion 29(1)) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 read with SEBI (Prohibition of Insider Trading) Regulations, 2015 (Regulation 7(2) read with Regulation 6(2)).

With reference to the above please find the enclosed disclosure under Regulation 29(1) of SEBI (Substantial acquisition of shares and takeover) Regulation 2011 and Regulation 7 (2) of SEBI (Prohibition of insider trading) Regulations 2015, received from Potluri Laboratories Private limited and also from Ramesh Babu Potluri.

This is for your information and Records.

Your faithfully For SMS Pharmaceuticals Limited

V.S.Venkatish Company Secretary

Potluri Laboratories Private Limited

Plot No.72, H. NO.8-2-334/3 & 4, 6th Floor, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - Telangana,500034 INDIA. Tel No.8978377337 Email: potlurilabs@gmail.com CIN NO: U24233TG1 993PTC015678

Dated: 18.08.2020

To,

The Manager, Corporate Filings Department, BSE Lim ited, Phiroze Jeejeebhoy Towers, Da la I Street, Mumbai- 400 001 Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/l, G Block, Bandra-Kurla Complex, Bandra (El. Mumbai - 400 051. Symbol: SMSPHARMA

Company Secretary SMS Pharmaceuticals Limited Plot.No. 72, H.No. 8-2-334/3&4, Road NO.5 Opp. SBI Executive Enclave, ~anjara Hills, Hyderabad.

Dear Sir, .

Sub: Reporting under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 read with SEBI (Prohibition of Insider Trading) Regulations, 201S (Regulation 7(2) read with Regulation 6(2))

)

With reference to the above subject, please find the enclosed herewith the reporting under regulation 29(1) of the SEBI (Substantial Acquisition of shares and takeover) Regulations and Regulation 7(2) read with Regulation 6(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 in respect of the acquisition (Purchase) of Shares from Mr. Ramesh Babu Potluri on 17'h August, 2020.

This is for your information and records.

For Potluri Laboratories Private Limited

Hima Bindu Potluri Director

Format for disclosures under Regulation 29(1) of SEBI (Snbstantial Acquisition of Shares and Takeovers) Regulations, 2011

Part - A - Details of the Acquisition

	Name of the Target Com [Jan)' (TC_) __________ ~S Pharmaceuticals Limited
	Name(s) of the acquirer and Persons Acting in		Potluri Laboratories Private Limited
	S:oncert (PAC) with the acquirer---------
	Whethertheacquirerbelongsto	--Yes
	Promoter/Promoter grou[J
	Name(s) of the Stock Exchange(s) where the	--BSE&NSE
	shares of TC are Listed
	Details of the acquisition as follows	Numbel·	% w.r.t. total	% w.r.t.
			share/voting	total diluted
			capital	share/voting
			wherever	capital of
			applicable	the TC (*)
	Before the acquisitionl under consideration,	2,32,420	0.27
	holding of acquirer along with the P ACs of :
a)	Shares carrying voting rights
b)	Sharesof encumbrancethenaturein
	Voting rights (VR)otherwise thanby
	equity shares
c)	Warrants/convertible securities/any other
	instrument that entitles the acquirer to
	receive shares carrying voting rights in the
	TC (specifv holding in each categorv)d) Total(a+b+cl
	Details of acquisition/sale	2,32,4204,22,000	0.270.50
a)	Shares carrying voting rights acquired
b)	VRs acquired otherwise than by equity
	shares
c)	Warrants/convertible securities/any other
	instrument that entitles the acquirer to
	receive shares carrying voting rights in the
	TC (specify holding in each category)
	acauired/sold
	d) Total (a+b+c)	4,22,000	0.50
	After the acquisition/sale, helding of:	6,54,420	0.77
a)	Shares carrying voting rights
b)	VRs otherwise than by equity shares
c)	Warrants/conveltible securities/any other
	instrument that entitles the acquirer to
	receive shares carrying voting rights in the
	TC (specify holding m each category)
	after acauisition

			1=
d) Total (a+b+c)	6T4A20--lJj]7
Mode of acquisition/sale (c.g. open market /		From both the stock exchanges (BSE & NSE)
off-market/publicIssue/rightsissue	Open Market
/preferential allotment / inter-se transfer etc.)
Date of acquisition / sale of shares / VR or date	J 7-08-2020
of receipt of intimation of allotment of shares,
whichever is applicable
Equity share capital/total voting capital of the		8,46,52,030 Equity Shares of Re 1/-	(Rupee
TC before the said acquisition/sale		one each) aggregating to Rs. 8,46,52,030
Equity share capital! total voting capital of the		8,46,52,030 Equity Shares of Re 1/-	(Rupee
TC after the said acquisition/sale		one each) aggregating to Rs. 8,46,52,030
Total diluted share/voting capital of the TC	NA
after the said acquisition/sale

For Potluri Laboratories Private Limited

Hima Bindn Potluri Director

Place: Hyderabad Date: 18.08.2020

FORMC

Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (2) read with Regulation 6(2)]

Name of the company: SMS Pharmaceuticals Limited

ISIN of the company: INE812GOI025

Details of change in holding of Securities of Promoter. Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).

Name,PAN No.,CIN/DIN,& addressof	Categoryof Person(promoters/KMP/Directors/	Securities heldprior toacquisition/	disfl9sal/ Release	Securities	acquired/ Disp ased/ release/			Securities held postrelease	acquisition/dispesal/	Date of11"'J,.,_"-ad-viEe/acquisition ofshares/		Dateofintimalion toccmpa	Mode ofI,Acquisiti! on/Disposal(market
Promoter/Employee/Director	immediaterelatives/others									sale of sharesq>eEify-I1>1 ,"",	release sf	ny	purchase/publicrights/
withcontactnos.	etc.)	Typeofseeurity(Foreg.-SharesWarrants,ConvertibleDebentures etel	No.and %ofshareholding	Type ofsecurity(For eg.-Shares,Warrants,ConvertibleDebenturesetc.)	I No.	Value	TransactionType(Buy/Sale/Pledge /Revoke/Invoke)release	Type ofsecurity(For egoShares,WarrantsConvertibleDebentures etc.)	No. and %ofshareholding	From	I To		preferentialoffer / offmarket/Inter-setransferetcI
1	2	3	4	5	6	7	8	9	10	11	12	13	I 14
POTLURILABORATORIESPRIVATELIMITED PAN:AAACH5037PH.No: Plot No:72, H.No. 8-2-334/3&4,6thFloor, Road No.5, opp. SBIExecutiveEnclave, BanjaraHills,500034.	Promoter	Equityshares	2,32,4200.27	EquityShares	4,22,000	Rs.3,94,35,900/-	Purchase	EquityShares	6,54,4200.50	17-08-2020	17-08-2020	18.08.2020	FrombothStockExchanges (BSE &NSE)openmarket

~1 .:' l--L\YlC"- '- Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2)

	Trading in derivatives (Specify type of contract, Futores or Options etc)					Exchange on which thetrade was executed
Type of	Contract	Buy		Sen
Contract	Specifications	Notional Value	Number of units(contracts * lotsize)	Notional Value	Number of units(contracts * lotsize)
15	16	17	18	19	20	21
			Na

For Potluri Laboratories Private Limited

~ BULJu- ·P·

Signature: Hima Bindu Potluri Director

Date: 18.08.2020 Place: Hyderabad

Dated: 18.08.2020

To

The Manager, Corporate Fi lings Department, BSE Limited, Ph iroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Ba ndra (E), Mumbai - 400 OSlo Symbol: SMSPHARMA

Company Secretary SMS Pharmaceuticals Limited Plot.No. 72, H.No. 8-2-334/ 3&4, Road No.5 Opp. SBI Executive Enclave, Banjara Hills, Hyderabad.

Dear Sir,

Sub: Reporting under Regulation 29(1)) of SEBI (Substantial Acq uisit ion of Sha res and Takeovers) Regulations, 2011 read with SEBI (Prohibition of Insider Trading) Regulations, 2015 (Regulation 7(2) read with Regulation 6(2)).

With reference to t he above subject, please find t he enclosed herewith the reporti ng under regulation 29(1) of the SEBI (Substantial Acquisition of shares and takeover) Regulations and Regulation 7(2) read with Regulation 6(2) of Securities and Exchange Board of India (Prohibition of Insider Tra ding) Regulations, 2015 in respect of the Sa le of Shares by Mr. Ramesh Babu Potluri in SMS Pharmaceutica ls Limited to Potluri Laboratories Private Limited on 17th August, 2020.

This is for your information and records.

Ra mesh Babu Pot luri

Format for disclosures under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Part - A - Details of the Acquisition / Sale

Name of the Target Company (TC)	SMS Pharmaceuticals Limited
Name(s) of the aequirer / seller and Persons	Ramesh Babu Potluri
Acting in Concert (PAC) with the aequirer/
seller
Whethertheacquirerbelongsto	Yes
Promoter/Promoter group
Name(s) of the Stock Exchange(s) where theshares of TC are Listed	BSE&NSE
Details of the aequisition / Sale as follows	Number	% w.r.t. total	% w.r.t.
		share/voting	total diluted
		capital	share/voting
		wherever	l ofcapita
		applicable	the TC (*)
theBeforeaequisitionSaleunder/	1,45,06,960	17.14
consideration, holding of aequiFer/ Seller
along with the PACs of:
a)Shares carrying voting rights
of encum branceb)Sharesthenaturein
Voting rights (VR) otherwise thanby
equity shares
c)Warrants/convertible securities/any other
instrument that entitles the acquirer to
receive shares carrying voting rights in the
TC (specify holding in each category)d) Total (a+b+c)	1,45,06,960	17.14
Details of aequisition/sale	4,22,000	0.50
a)Shares carrying voting rights acquired
b)VRs acquired otherwise than by equity
shares
c)Warrants/convertible securities/any other
instrument that entitles the acquirer to
receive shares carrying voting rights in the
TC (specify holding ineach category)
acquired/sold
d) Total (a+b+c)	4,22,000	0.50
After the aequisition/sale, holding of:	1,40,84,960	16.64
a)Shares carrying voting rights
b)VRs otherwise than by equity shares
c)Warrants/convertible securities/any other
instrument that entitles the acquirer to
receive shares carrying voting rights in the

TC (specify holding In each category)after acquisition
d) Total (a+b+c)	16.641,40,84,960
Mode of aequisitiell/sale (e.g. open market 1	Through the both the Stock Exchanges (BSE &
off-market1 publicissue1 rightsissue	NSE) Open Market
Ipreferential allotment 1 inter-se transfer etc.)
Date of asquisitiell 1 sale of shares 1 VR or date	17-08-2020
of receipt of intimation of allotment of shares,
whichever is applicable
Equity share capital 1 total voting capital of the	8,46,52,030 Equity Shares of Re 1/-(Rupee
TC before the saidIsale	one each) aggregating to Rs. 8,46,52,030
Equity share capitall total voting capital of the	8,46,52,030 Equity Shares ofRe 1/-(Rupee
TC after the saidIsale	one each) aggregating to Rs. 8,46,52,030
of the TCTotal diluted share/voting capital	NA
Isaleafter the said

Ramcsh Babu Potluri

Place: Hyderabad Date: 18.08.2020

FORMC

Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (2) read with Regulation 6(2)]

Name of the company: SMS Pharmaceuticals Limited

ISIN of the company: INE812GOI025

Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2),

Name,PANNa.,CIN/DIN,& addressofPromoter/Employee /Director	Categoryof Person(promoters/KMP/Directors/immediaterelatives/others	Securities heldprior toaCEJ:u:isiSSR/	disposal! Release	Securities	aEEf:lireel/Disposed/ release/			Securities held postrelease	aCEJ:\iisiasn/disposal/	Date ofalletme"t/aEEf:lisitieR 8£sha <es <br="">sale of shares:r.eify	lease sf	Dateofintimation tocompany	Mode ofACEIl:l:isieen/Disposal(marketpurchase/publicrights/
withcontactnos.	etc.)	Typeofsecurity(Foreg.-Shares,Warrants,ConvertibleDebentures etc.)	No.and %ofshareholding	Type ofsecurity(For eg.-Shares,Warrants,ConvertibleDebenturesetc.)	No.	Value	TransactionType(Buy/Sale/Pledge /Revoke/Invoke)release	Type ofsecurity(For ego-Shares,Warrants,ConvertibleDebentures etc.)	No. and %ofshareholding	From	To		preferentialoffer / offmarket/Inter-setransferetc
1	2	3	4	5	6	7	8	9	10	11	12	13	14
Ramesh SabuPotluriPAN:ADFPP2514CH.No: Plot No:2650, Road No.10, Jubilee HillsHyderabad-500034	Promoter	Equityshares	1,45,06,960	EquityShares	4,22,000	Rs.3,94,35,900/-	sale	EquityShares	1,40,84,960	17.08.2020Sale	17.08.2020	18.08.2020	Salethroughboth thestockexchange(BSE&NSE)openmarket

v

Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2}

	Trading in derivatives (Specify type of contract, Futures or Options etc)					Exchange on which thetrade was executed
Type of	Contract	BuV		Sell
Contract	Specifications	Notional Value	Number of units(contracts 1t lotsize)	Notional Value	Number of units(contracts * lotsize)
15	16	17	18	19	20	21
			Na

v

Vr

Signature: Rarnesh Babu Potluri

Date: 18.08.2020 Place: Hyderabad